KRAS G12V Mutant Advanced Epithelial Cancers
1 clinical trials · Condition
◉ Watch KRAS G12V Mutant Advanced Epithelial Cancers
| Record | Firm | Date |
|---|---|---|
| Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors (NCT05389514) | Providence Health & Services |
Track KRAS G12V Mutant Advanced Epithelial Cancers automatically
Every clearance here is in the API, with alerts when new ones post.